Concepedia

Shota Miyake

SM

6

Publications

359

Citations

6

H-Index

1982

Active since

Affiliations

Ono Pharmaceutical (Japan)(Current)

Shota Miyake is an author at Ono Pharmaceutical (Japan) specializing in neuroimmunology, inflammation, and medicine.

ORCID

Top concepts

Publications per year

1982–2023

6

Publications

6

Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils.

Y Niwa, Shota Miyake, Tsuyoshi Sakane et al. · PubMed · 1982 · 201 citations · Full text

, , +20

New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD

Yukio Takeshita, Susumu Fujikawa, Kenichi Serizawa et al. · Neurology Neuroimmunology & Neuroinflammation · 2021 · 85 citations · Full text

Possible Involvement of Oxidative Stress in 5-Fluorouracil-Mediated Myelosuppression in Mice

Satoshi Numazawa, Kazuko Sugihara, Shota Miyake et al. · Basic & Clinical Pharmacology & Toxicology · 2010 · 36 citations

Allergin-1 inhibits TLR2-mediated mast cell activation and suppresses dermatitis.

Satoshi Tsurusaki, Satoko Tahara‐Hanaoka, Shohei Shibagaki et al. · International Immunology · 2016 · 13 citations · Full text

Intradermal AQP4 peptide immunization induces clinical features of neuromyelitis optica spectrum disorder in mice

Kenichi Serizawa, Shota Miyake, Yoshichika Katsura et al. · Journal of Neuroimmunology · 2023 · 13 citations · Full text

, , +20

Rows per page

1–5 of 6